Complete mass spectral characterization of a synthetic ultralow-molecular-weight heparin using collision-induced dissociation.

Glycosaminoglycans (GAGs) are a class of biologically important molecules, and their structural analysis is the target of considerable research effort. Advances in tandem mass spectrometry (MS/MS) have recently enabled the structural characterization of several classes of GAGs; however, the highly sulfated GAGs, such as heparins, have remained a relatively intractable class due their tendency to lose SO(3) during MS/MS, producing few sequence-informative fragment ions. The present work demonstrates for the first time the complete structural characterization of the highly sulfated heparin-based drug Arixtra. This was achieved by Na(+)/H(+) exchange to create a more ionized species that was stable against SO(3) loss, and that produced complete sets of both glycosidic and cross-ring fragment ions. MS/MS enables the complete structural determination of Arixtra, including the stereochemistry of its uronic acid residues, and suggests an approach for solving the structure of more complex, highly sulfated heparin-based drugs.

[1]  Christopher J. Jones,et al.  Heparin characterization: challenges and solutions. , 2011, Annual review of analytical chemistry.

[2]  Robert J Linhardt,et al.  Negative electron transfer dissociation of glycosaminoglycans. , 2010, Analytical chemistry.

[3]  S. Nielsen,et al.  Structural characterization of negatively charged glycosaminoglycans using high-energy (50-150 keV) collisional activation , 2009 .

[4]  Robert J Linhardt,et al.  Influence of charge state and sodium cationization on the electron detachment dissociation and infrared multiphoton dissociation of glycosaminoglycan oligosaccharides , 2008, Journal of the American Society for Mass Spectrometry.

[5]  Robert J Linhardt,et al.  Distinguishing glucuronic from iduronic acid in glycosaminoglycan tetrasaccharides by using electron detachment dissociation. , 2007, Analytical chemistry.

[6]  Robert J Linhardt,et al.  Electron detachment dissociation of glycosaminoglycan tetrasaccharides , 2007, Journal of the American Society for Mass Spectrometry.

[7]  Catherine E Costello,et al.  Glycoform quantification of chondroitin/dermatan sulfate using a liquid chromatography-tandem mass spectrometry platform. , 2006, Biochemistry.

[8]  R. Linhardt,et al.  Mass Spectrometry for the Analysis of Highly Charged Sulfated Carbohydrates. , 2005, Current analytical chemistry.

[9]  P. Seeberger,et al.  Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans. , 2005, Chemistry & biology.

[10]  R. Linhardt,et al.  Chemistry and biology of heparin and heparan sulfate , 2005 .

[11]  J. Zaia,et al.  Competing fragmentation processes in tandem mass spectra of heparin-like glycosaminoglycans , 2004, Journal of the American Society for Mass Spectrometry.

[12]  J. Gebler,et al.  Electrospray ionization mass spectrometric analysis of nucleic acids using high-throughput on-line desalting. , 2004, Rapid communications in mass spectrometry : RCM.

[13]  C. V. van Boeckel,et al.  A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next? , 2004, Angewandte Chemie.

[14]  Robert J Linhardt,et al.  Liquid Chromatography/Mass Spectrometry Sequencing Approach for Highly Sulfated Heparin-derived Oligosaccharides* , 2004, Journal of Biological Chemistry.

[15]  Catherine E. Costello,et al.  Tandem mass spectrometric strategies for determination of sulfation positions and uronic acid epimerization in chondroitin sulfate oligosaccharides , 2003, Journal of the American Society for Mass Spectrometry.

[16]  Balagurunathan Kuberan,et al.  Enzymatic synthesis of antithrombin III–binding heparan sulfate pentasaccharide , 2003, Nature Biotechnology.

[17]  J. Leary,et al.  Compositional analysis and quantification of heparin and heparan sulfate by electrospray ionization ion trap mass spectrometry. , 2003, Analytical chemistry.

[18]  Catherine E Costello,et al.  Tandem mass spectrometry of sulfated heparin-like glycosaminoglycan oligosaccharides. , 2003, Analytical chemistry.

[19]  J. Zaia,et al.  Influence of charge state on product ion mass spectra and the determination of 4S/6S sulfation sequence of chondroitin sulfate oligosaccharides. , 2002, Analytical chemistry.

[20]  D. Rabenstein.  Heparin and heparan sulfate: structure and function. , 2002, Natural product reports.

[21]  Z. Shriver,et al.  Dynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycans. , 2002, Seminars in thrombosis and hemostasis.

[22]  G. Jayson,et al.  Heparan sulfate proteoglycans and cancer , 2001, British Journal of Cancer.

[23]  I. Vlodavsky,et al.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. , 2001, The Journal of clinical investigation.

[24]  M. Gilar,et al.  High-throughput biopolymer desalting by solid-phase extraction prior to mass spectrometric analysis. , 2001, Journal of chromatography. A.

[25]  P. Hilgard,et al.  Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes , 2000, Hepatology.

[26]  Pietro Traldi,et al.  Rapid Commun. Mass Spectrom.10. 1629-1637 (1996) Matrix-assisted Laser Desorption/Ionisation Mass Spectrometry in Milk Science , 1997 .

[27]  M. Klagsbrun,et al.  Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate , 1993, The Journal of cell biology.

[28]  L. Kjellén,et al.  Proteoglycans: structures and interactions. , 1991, Annual review of biochemistry.

[29]  R. Rosenberg,et al.  Correlation between structure and function of heparin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.